Despite the typical mutations known from tissue biopsies, partly being relevant for therapeutic decisions, there is a chance for additional markers as candidates for liquid biopsy, including some splice variants of CD44, which can be found in glioblastomas, but often restricted to clusters of tumor cells in the tumor tissue [90]. Here, CD44 is linked to glioblastoma.